We are live on ! Find out more
AMCA

Arthur M. Cohen & Associates Portfolio holdings

AUM $563M
1-Year Est. Return 20.97%
This Fund
S&P 500
This Quarter Est. Return
+2.17%
1 Year Est. Return
+20.97%
3 Year Est. Return
+97.14%
5 Year Est. Return
+130.41%
10 Year Est. Return
AUM
$255M
AUM Growth
+$31.5M
Cap. Flow
+$126M
Cap. Flow %
49.21%
Top 10 Hldgs %
51.07%
Holding
107
New
13
Increased
31
Reduced
37
Closed
9

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$3.89M
2
HSY icon
Hershey
HSY
+$2.78M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.44M
4
PM icon
Philip Morris
PM
+$1.07M
5
TMO icon
Thermo Fisher Scientific
TMO
+$774K

Sector Composition

Rank Sector Weight
1 Healthcare 23.65%
2 Financials 20.8%
3 Consumer Staples 13.68%
4 Technology 10.06%
5 Communication Services 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASMB icon
76
Assembly Biosciences
ASMB
$524M
$403K 0.16%
+1,625
New +$458K
AGIO icon
77
Agios Pharmaceuticals
AGIO
$1.9B
$397K 0.16%
+7,612
New +$389K
IVV icon
78
iShares Core S&P 500 ETF
IVV
$900B
$396K 0.16%
1,625
EPD icon
79
Enterprise Products Partners
EPD
$82.5B
$392K 0.15%
14,400
PFE icon
80
Pfizer
PFE
$151B
$367K 0.14%
11,462
-2,414
-17% -$76.1K
IWR icon
81
iShares Russell Mid-Cap ETF
IWR
$57.4B
$342K 0.13%
7,088
BLUE
82
DELISTED
bluebird bio
BLUE
$338K 0.13%
+248
New +$299K
MO icon
83
Altria Group
MO
$114B
$336K 0.13%
4,400
ABT icon
84
Abbott
ABT
$186B
$311K 0.12%
6,391
KDP icon
85
Keurig Dr Pepper
KDP
$40.9B
$311K 0.12%
3,400
+925
+37% +$86.5K
RJF icon
86
Raymond James Financial
RJF
$34.1B
$302K 0.12%
5,550
INTC icon
87
Intel
INTC
$508B
$300K 0.12%
8,945
+5,990
+203% +$214K
CRM icon
88
Salesforce
CRM
$157B
$294K 0.12%
+3,411
New +$297K
USG
89
DELISTED
Usg
USG
$284K 0.11%
9,765
RDS.B
90
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$281K 0.11%
+5,120
New +$285K
EEM icon
91
iShares MSCI Emerging Markets ETF
EEM
$29.4B
$278K 0.11%
6,663
-2,601
-28% -$106K
FIW icon
92
First Trust Water ETF
FIW
$1.94B
$259K 0.1%
6,012
+612
+11% +$25.9K
MB
93
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$235K 0.09%
+9,000
New +$248K
CERN
94
DELISTED
Cerner Corp
CERN
$225K 0.09%
+3,430
New +$219K
BDX icon
95
Becton Dickinson
BDX
$48.5B
$207K 0.08%
1,063
-615
-37% -$112K
JEF icon
96
Jefferies Financial Group
JEF
$13B
$205K 0.08%
8,524
-3,351
-28% -$76.3K
LPTH icon
97
Lightpath Technologies
LPTH
$794M
$121K 0.05%
45,000
-6,000
-12% -$16.8K
GNMX
98
DELISTED
Aevi Genomic Medicine Inc
GNMX
$42K 0.02%
+31,390
New +$45.4K
ADP icon
99
Automatic Data Processing
ADP
$108B
-3,010
Closed -$308K
CVX icon
100
Chevron
CVX
$367B
-4,156
Closed -$446K

Similar funds

Arthur M. Cohen & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Arthur M. Cohen & Associates held 107 positions worth $255M, up 14% from $224M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Arthur M. Cohen & Associates deployed $126M of net new capital in Q2 2017, opening 13 new positions and adding to 31 existing holdings. Its largest new stake was Alphabet (Google) Class C: 2,083,220 shares worth $4.91M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Eli Lilly, an estimated $3.89M trimmed.

  • Arthur M. Cohen & Associates's largest Q2 2017 buy was Alphabet (Google) Class C: 2,083,220 shares worth $4.91M.
  • Arthur M. Cohen & Associates added most to Brookfield Infrastructure Partners in Q2 2017, an estimated $18.4M increase.
  • Arthur M. Cohen & Associates's biggest Q2 2017 reduction was Eli Lilly, cutting an estimated $3.89M.
  • Arthur M. Cohen & Associates fully exited Chevron in Q2 2017, selling an estimated $446K.
  • Arthur M. Cohen & Associates's ten largest holdings make up 51% of its $255M portfolio in Q2 2017.
  • Arthur M. Cohen & Associates opened 13 new positions and closed 9 in Q2 2017.
  • Arthur M. Cohen & Associates's portfolio value rose 14% quarter-over-quarter to $255M.

Based on Arthur M. Cohen & Associates's 13F filing for Q2 2017, filed 27 Jul 2017.